Category:
Sera and Vaccines
CAS NO:
2023788-19-2
Standard:
USP,BP,EP,
Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.